Anika Therapeutics





Ebitda Cambiamento Data
Abbott USD 3.09B 44M 2025-09
Agenus USD -10.11M 19.02M 2025-03
Agios Pharmaceuticals USD -125.8M 20.45M 2025-06
Anika Therapeutics USD -2.69M 4.73M 2025-03
Arrowhead Research USD 64.2M 223.53M 2025-09
Halozyme Therapeutics USD 248.25M 22.74M 2025-09
Heron Therapeutics USD -3.88M 5.63M 2024-09
Insmed USD -297.13M 71.11M 2025-06
Integra LifeSciences USD 78.45M 550.67M 2025-09
Intrexon USD -24.7M 2.92M 2024-06
J&J USD 9.52B 389M 2025-09
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Ligand Pharmaceuticals USD 20.9M 61.44M 2025-06
MacroGenics USD 21.95M 55.39M 2025-09
Merit Medical Systems USD 83.96M 10.65M 2025-06
Rigel Pharmaceuticals USD -4.17M 798K 2023-09
Sanofi EUR 4.84B 2.95B 2025-09
Smith & Nephew USD 796M 139M 2025-12
Stryker USD 1.67B 206M 2025-09
Surmodics USD 1.53M 485K 2024-09
Veracyte USD 39.73M 3.96M 2025-09
Xencor USD -30.52M 6.39M 2025-06
Zimmer Biomet Holdings USD 759M 120.8M 2025-12


Anika Therapeutics - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.